Prostamax — Khavinson bioregulator — prostate (injectable pharmaceutical)
Prostamax/Prostatilen is a polypeptide complex from bovine prostate. The pharmaceutical-grade Prostatilen is approved in Russia for prostate conditions. Similar target tissue to Libidon but more data — used clinically for BPH, chronic prostatitis, and male fertility support. Restores prostate cell gene expression, reduces prostatic inflammation, and improves urodynamics.
نظرة عامة
هذه الصفحة جزء من مكتبة المركّبات المُصنَّفة بالأدلة في Hormonaly. جميع الادعاءات السريرية مرتبطة بمصادر علمية مُحكَّمة عبر خط أنابيب التحقق المزدوج للاستشهادات.
فئة المركّب
Khavinson bioregulator — prostate (injectable pharmaceutical)
آلية العمل
Prostamax/Prostatilen is a polypeptide complex from bovine prostate. The pharmaceutical-grade Prostatilen is approved in Russia for prostate conditions. Similar target tissue to Libidon but more data — used clinically for BPH, chronic prostatitis, and male fertility support. Restores prostate cell gene expression, reduces prostatic inflammation, and improves urodynamics.
الوضع التنظيمي
Not FDA approved in US. Russian pharmaceutical drug (Prostatilen). Approved in Russia for BPH and chronic prostatitis.
مستوى الأدلة
Low-Moderate — Registered pharmaceutical in Russia with clinical data for BPH and prostatitis. More data than Libidon but still limited by Western standards.